Protalix BioTherapeutics (PLX) Net Margin (2010 - 2026)
Protalix BioTherapeutics' quarterly Net Margin came in at 54.27% in Q1 2026, up 9006.0% year-on-year from 0.6% in Q1 2025, and up 214.81% quarter-over-quarter from 47.27% in Q4 2025.
Protalix BioTherapeutics has reported Net Margin for 17 years, with the latest figure at 54.27% in Q1 2026.
- For the quarter ending Q1 2026, Net Margin rose 9006.0% year-over-year to 54.27%; the trailing twelve-month figure through Mar 2026 stood at 22.01% (up 826.0% YoY), and the FY2025 full-year result was 9.93%, down 2393.0% from the prior year.
- Net Margin for Q1 2026 stood at 54.27%, up from 47.27% in the prior quarter.
- The five-year high for Net Margin was 59.31% in Q4 2024, with the low at 236.15% in Q4 2023.
- Average Net Margin over 5 years is 26.61%, with a median of 17.9% recorded in 2023.
- Year-over-year, Net Margin plunged 19890 bps in 2023 and soared 29547 bps in 2024.
- Tracing PLX's Net Margin over 5 years: stood at 37.25% in 2022, then slumped by 534 bps to 236.15% in 2023, then soared by 125 bps to 59.31% in 2024, then tumbled by 180 bps to 47.27% in 2025, then soared by 215 bps to 54.27% in 2026.
- The last three Net Margin figures came in at 54.27% (Q1 2026), 47.27% (Q4 2025), and 13.52% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 0.82% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 34.53% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 20.17% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 17.65% |
| 10 | Protalix BioTherapeutics | 164.49 Mn | 153.70 Mn | 29.62 Mn | 54.27% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 54.27% |
| Dec 31, 2025 | -47.27% |
| Sep 30, 2025 | 13.52% |
| Jun 30, 2025 | 2.52% |
| Mar 31, 2025 | -35.79% |
| Dec 31, 2024 | 59.31% |
| Sep 30, 2024 | 18.02% |
| Jun 30, 2024 | -16.35% |
| Mar 31, 2024 | -122.60% |
| Dec 31, 2023 | -236.15% |
| Sep 30, 2023 | -17.90% |
| Jun 30, 2023 | 46.21% |
| Mar 31, 2023 | -32.66% |
| Dec 31, 2022 | -37.25% |
| Sep 30, 2022 | -25.15% |
| Jun 30, 2022 | -60.94% |
| Mar 31, 2022 | -14.21% |
| Dec 31, 2021 | -77.37% |
| Sep 30, 2021 | -35.63% |
| Jun 30, 2021 | -176.89% |
| Mar 31, 2021 | -51.78% |
| Dec 31, 2020 | 1.63% |
| Sep 30, 2020 | -42.22% |
| Jun 30, 2020 | -38.19% |
| Mar 31, 2020 | 6.76% |
| Dec 31, 2019 | 0.79% |
| Sep 30, 2019 | -25.22% |
| Jun 30, 2019 | -63.25% |
| Mar 31, 2019 | -71.41% |
| Dec 31, 2018 | -315.09% |
| Sep 30, 2018 | -837.41% |
| Jun 30, 2018 | -425.57% |
| Mar 31, 2018 | -161.89% |
| Dec 31, 2017 | -583.22% |
| Jun 30, 2016 | -6.61% |
| Mar 31, 2016 | -10.60% |
| Sep 30, 2015 | 164.30% |
| Jun 30, 2015 | 83.23% |
| Mar 31, 2015 | 31.97% |
| Mar 31, 2014 | -110.26% |
| Dec 31, 2013 | 210.63% |
| Sep 30, 2013 | -247.15% |
| Jun 30, 2013 | -304.51% |
| Mar 31, 2013 | -124.52% |
| Dec 31, 2012 | -867.49% |
| Sep 30, 2012 | -149.30% |
| Jun 30, 2012 | 36.84% |
| Mar 31, 2012 | -157.08% |
| Dec 31, 2011 | -375.02% |
| Sep 30, 2011 | -774.47% |
| Jun 30, 2011 | -1,815.18% |
| Mar 31, 2011 | -122.04% |
| Dec 31, 2010 | -752.38% |
| Sep 30, 2010 | -89.45% |
| Jun 30, 2010 | -889.57% |